1. Home
  2. MRTN vs NVCR Comparison

MRTN vs NVCR Comparison

Compare MRTN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marten Transport Ltd.

MRTN

Marten Transport Ltd.

HOLD

Current Price

$14.69

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.87

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRTN
NVCR
Founded
1946
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
MRTN
NVCR
Price
$14.69
$15.87
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$28.08
AVG Volume (30 Days)
843.9K
1.5M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
1.61%
N/A
EPS Growth
N/A
21.79
EPS
0.21
N/A
Revenue
$1,131,455,000.00
$655,353,000.00
Revenue This Year
$2.23
$7.72
Revenue Next Year
$8.59
$6.74
P/E Ratio
$69.14
N/A
Revenue Growth
N/A
8.28
52 Week Low
$9.35
$9.82
52 Week High
$15.31
$20.05

Technical Indicators

Market Signals
Indicator
MRTN
NVCR
Relative Strength Index (RSI) 57.55 67.83
Support Level $14.20 $12.66
Resistance Level $15.31 N/A
Average True Range (ATR) 0.47 0.79
MACD -0.06 0.50
Stochastic Oscillator 56.64 77.54

Price Performance

Historical Comparison
MRTN
NVCR

About MRTN Marten Transport Ltd.

Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: